SEC Form 4 · accession 0001213900-26-101594
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Janet Dillione
Director
Period of report
Sep 18, 2026
Accepted (ET)
Sep 18, 2026 · 9:36 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001410098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 18, 2026 | M | 48,909 | — | A | 117,835 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom StockF1 | — | Sep 18, 2026 | M | 48,909 | D | — | — | Common Stock | 48,909 | 0 | D |
Explanation of responses
- F1Each phantom stock unit is the economic equivalent of one share of common stock. On September 17, 2025, the Company terminated the CorMedix Inc. Deferred Compensation Plan for Directors (the "Plan"). On September 18, 2026, in connection with the termination of the Plan, all of the Reporting Person's phantom stock units were settled in an equal number of shares of common stock.